TD Cowen downgraded CareMax from Outperform to Market Perform and set a new price target of $4.00 from $7.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/26/2024 | $1.50 → $7.50 | Buy → Hold | Jefferies |
| 11/17/2023 | $5.00 → $1.00 | Buy → Neutral | UBS |
| 11/10/2023 | $3.00 → $2.00 | Overweight → Neutral | Piper Sandler |
| 3/17/2023 | $7.00 → $4.00 | Outperform → Market Perform | TD Cowen |
| 9/7/2022 | $7.50 | Hold | Truist |
| 1/7/2022 | $14.00 | Buy | UBS |
| 10/20/2021 | $15.00 | Buy | Jefferies |
| 9/13/2021 | $14.00 | Neutral → Overweight | Piper Sandler |
3 - CareMax, Inc. (0001813914) (Issuer)
3 - CareMax, Inc. (0001813914) (Issuer)
4 - CareMax, Inc. (0001813914) (Issuer)
Jefferies downgraded CareMax from Buy to Hold and set a new price target of $7.50 from $1.50 previously
UBS downgraded CareMax from Buy to Neutral and set a new price target of $1.00 from $5.00 previously
Piper Sandler downgraded CareMax from Overweight to Neutral and set a new price target of $2.00 from $3.00 previously
SC 13G/A - CareMax, Inc. (0001813914) (Subject)
SC 13G - CareMax, Inc. (0001813914) (Subject)
SC 13D/A - CareMax, Inc. (0001813914) (Subject)
Met 2023 Guidance for Medicare Advantage Membership and Total Revenue Year-end 2023 Medicare Advantage Membership of 111,500, up 19% year-over-year Full Year 2023 Total Revenue of $751.1 million, up 19% year-over-year Exploring Strategic Options to Maximize Value of Certain Assets and Generate Further Liquidity CareMax, Inc. (NASDAQ:CMAX, CMAXW))) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced financial results for the fourth quarter and full year ended December 31, 2023. "In the fourth quarter, we began taking major steps with the goal of solidifying the long-term viability of our business," said Carlos de Solo, C
Third Quarter Medicare Advantage Membership of 107,000, up 171% year-over-year Third Quarter Total Revenue of $201.8 million, up 28% year-over-year Reaffirming Full Year 2023 Revenue Guidance; Updating Full Year 2023 Medicare Advantage Membership and Adjusted EBITDA Guidance CareMax, Inc. (NASDAQ:CMAX, CMAXW))) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced financial results for the third quarter ended September 30, 2023. "Tomorrow marks one year since the acquisition of our national MSO and nearly two and a half years of rapid growth in our patient and provider base. Over that period, we experienced fluctuations in o
CareMax, Inc. ("CareMax") (NASDAQ:CMAX, CMAXW))), a leading value-based care delivery system, announced today that it will release its financial results for the third quarter 2023 before the opening of the financial markets on Thursday, November 9, 2023, and host a conference call at 8:30 am Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (888) 330-2508 for U.S. participants, or (240) 789-2735 for international participants, and referencing conference ID 7874605. A live audio webcast and replay of the event will also be available on the "Events & Presentations" section of CareMax's investor relations website at ir.caremax.com. About CareM
8-K - CareMax, Inc. (0001813914) (Filer)
NT 10-Q - CareMax, Inc. (0001813914) (Filer)
8-K - CareMax, Inc. (0001813914) (Filer)
Revere Medical Enters into Agreement to Acquire CareMax's Management Services Organization Agreement in Principle Reached with "Stalking Horse" for Core Centers' Assets Sale Transactions to be Implemented Through an Expedited Prearranged Chapter 11 Plan Supported by 100% of CareMax's Secured Lenders CareMax Secures $30.5 Million in Debtor in Possession Financing to Support Operations and Continuing Provision of Healthcare Services Throughout Restructuring Process CareMax, Inc. (NASDAQ:CMAX, CMAXW)) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced it has entered into an agreement to sell its management services organization
Second Quarter Medicare Advantage Membership of 104,000, up 1% year-over-year Second Quarter Total Revenue of $198.6 million, down 12% year-over-year CareMax, Inc. (NASDAQ:CMAX, CMAXW))) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced financial results for the second quarter ended June 30, 2024. "Although our medical expense ratio continued to run higher than target levels, we were able to manage toward another quarter of sequential improvement in MER in the second quarter, and we continued to make progress against our clinical initiatives," said Carlos de Solo, Chief Executive Officer. Mr. de Solo continued, "Additiona
First Quarter Medicare Advantage Membership of 107,000, up 12% year-over-year First Quarter Total Revenue of $232.2 million, up 34% year-over-year Continuing to Explore Strategic Options to Maximize Value of Certain Assets and Generate Further Liquidity CareMax, Inc. (NASDAQ:CMAX, CMAXW))) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced financial results for the first quarter ended March 31, 2024. "During the first quarter of 2024, we believe we began to see benefits from our fourth quarter clinical efforts which became fully implemented toward the end of last year," said Carlos de Solo, Chief Executive Officer. "While
Steward Health Care, the nation's largest physician-led health care network, today announced the appointment of Rubén José King-Shaw Jr to its Board of Directors. King-Shaw currently serves as Steward's Executive Vice President & Chief Strategy Officer, where he has led a number of critical strategic acquisitions and divestitures including the sale of Steward Health Choice Arizona and the significant merger of Steward's value-based Medicare business with Caremax (NASDAQ:CMAX). King-Shaw also chairs Steward's offshore captive insurance company, TRACO, which is domiciled in Panamá. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220
CareMax, Inc. ("CareMax") (NASDAQ:CMAX, CMAXW))), a leading technology-enabled provider of value-based care to seniors, today announced the appointment of Mr. Jose R. Rodriguez as Chair of CareMax's board of directors, to succeed Mr. Richard A. Barasch, who has resigned from the Board. Mr. Rodriguez has served as a member of CareMax's board of directors since June 2021 and previously served as CareMax's Lead Independent Director. Mr. Barasch will continue to serve as an advisor to CareMax's board of directors. "We are excited that Jose has agreed to lead CareMax's board of directors as we start our first full year as a public company. The board and I believe Jose's recognized leadership in
CareMax, Inc. ("CareMax") (NASDAQ:CMAX, CMAXW))), a leading technology-enabled provider of value-based care to seniors, today announced that Beatriz Assapimonwait has been appointed as an independent member of the CareMax board of directors. Ms. Assapimonwait brings to CareMax 38 years of Medicare managed care experience, including a decade of experience as a leader in the Medicare markets in South Florida, North Florida, and Puerto Rico. Most recently, Ms. Assapimonwait served as the Regional President for Humana South Florida where she was responsible for developing market strategies and leading market operations. Before that, Ms. Assapimonwait was CEO of Family Physicians of Winter Park
Shares of Comcast Corporation (NASDAQ:CMCSA) fell sharply during Tuesday's session after the company reported worse-than-expected second-quarter sales results. Comcast reported second-quarter revenue decline of 2.7% year-over-year to $29.69 billion, missing the analyst consensus estimate of $30.02 billion.The company reported adjusted EPS of $1.21, beating analyst consensus estimates of $1.12, according to data from Benzinga Pro. Comcast shares declined 6.1% to $37.12 on Tuesday. Here are some other stocks moving in today’s mid-day session. Gainers Azitra, Inc. (NYSE:AZTR) shares jumped 529% to $10.19 after the company announced that the U.S. Patent and Trademark Office grant
Shares of SAP SE (NYSE:SAP) rose sharply in today's pre-market trading after the company reported second-quarter financial results. SAP reported quarterly earnings of 82 cents per share which missed the analyst consensus estimate of $1.19 per share. Quarterly sales came in at $8.92 billion which missed the analyst consensus estimate of $8.96 billion, representing an 8.81% increase over sales from the same period last year, according to data from Benzinga Pro. SAP shares gained 5.9% to $212.34 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Nature’s Miracle Holding Inc. (NASDAQ:NMHI) rose 183.4% to $0.9779 in pre-market trading after fal